Fremont, CA, United States of America

Dan Xu

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Leland Stanford Junior University. Active years: 2018-2022.

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Dan Xu in Hepatocyte-Like Cell Production

Introduction

Dan Xu is an accomplished inventor based in Fremont, CA (US). She has made significant contributions to the field of regenerative medicine, particularly in the production of hepatocyte-like cells. With a total of 2 patents, her work is paving the way for advancements in cell therapy and treatment methodologies.

Latest Patents

Dan Xu's latest patents focus on methods and compositions for producing hepatocyte-like cells (iHeps) from adipocyte-derived stem cells (ASCs). The methods involve placing a population of ASCs into a three-dimensional culture, utilizing various techniques such as hanging drop suspension culture, high-density culture, spinner flask culture, and microcarrier culture. The cells are then contacted with a first and second culture medium. Additionally, the patents describe methods for treating individuals by producing a population of iHeps from ASCs and administering an effective number of iHeps to the individual. Kits for practicing these methods are also included in her patents.

Career Highlights

Dan Xu is affiliated with Leland Stanford Junior University, where she continues her research and innovation in the field. Her work has garnered attention for its potential applications in treating liver diseases and advancing regenerative medicine.

Collaborations

Dan Xu has collaborated with notable colleagues, including Gary A. Peltz, enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Dan Xu's innovative work in producing hepatocyte-like cells represents a significant advancement in regenerative medicine. Her contributions are expected to have a lasting impact on the field and improve treatment options for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…